US 10293037
DNA vaccine for use in pancreatic cancer patients
granted A61KA61K2039/522A61K2039/523
Quick answer
US patent 10293037 (DNA vaccine for use in pancreatic cancer patients) held by Vaximm AG expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vaximm AG
- Grant date
- Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/522, A61K2039/523, A61K2039/53, A61K2039/542